Search results
Teva and Alvotech Announce SIMLANDI® (adalimumab-ryvk) Injection Now Available in the U.S.
Morningstar· 3 days ago“We are proud to make SIMLANDI available in the U.S. to patients and providers,” said Thomas Rainey, Senior Vice President, U.S...
Teva and Alvotech Announce SIMLANDI® (adalimumab-ryvk) Injection Now Available in the U.S.
Morningstar· 3 days ago“We are proud to make SIMLANDI available in the U.S. to patients and providers,” said Thomas Rainey, Senior Vice President, U.S...
State board targets six prescription drugs to review for affordability for Marylanders
Maryland Matters via Yahoo News· 3 days agoThe board will seek public comments, additional information and data over the next 60 days to...
India's Sun Pharma beats Q4 profit view on strong US, domestic sales
Reuters via Yahoo Finance· 2 days agoSun Pharma's U.S. sales rose nearly 11.9% to 39.54 billion rupees, boosted by speciality complex...
AbbVie Presents New Data Supporting Leading Gastroenterology Portfolio at 2024 Digestive Disease...
The Parsons Sun· 7 days ago- AbbVie will present 15 abstracts, including three oral presentations, in Crohn's disease and ulcerative colitis reinforcing AbbVie's commitment to advancing the standards of care in inflammatory bowel diseases (IBD)
Mizuho Boosts Arcutis Biotherapeutics (NASDAQ:ARQT) Price Target to $18.00
ETF DAILY NEWS· 6 days agoArcutis Biotherapeutics (NASDAQ:ARQT – Free Report) had its price target lifted by Mizuho from $17.00 to $18.00 in a report issued on Wednesday, Benzinga reports. They currently have a buy rating ...
Maintenance Tx With Guselkumab for UC Meets All Endpoints
Medscape· 2 days agoGuselkumab (Tremfya, Janssen/Johnson & Johnson) was superior to placebo for maintenance therapy in...
Alvotech (ALVO) Scheduled to Post Quarterly Earnings on Tuesday
ETF DAILY NEWS· 5 days agoAlvotech (NYSE:ALVO – Get Free Report) will post its quarterly earnings results after the market closes on Tuesday, May 21st. Individual interested in participating in the company’s earnings ...
Guselkumab Continues Winning Streak in Crohn's Disease
MedPage Today· 2 days agoInduction and maintenance treatment with guselkumab (Tremfya) demonstrated its safety and efficacy...
India's Sun Pharma beats Q4 profit view on strong US, domestic sales
Reuters· 2 days agoIndian drugmaker Sun Pharmaceutical Industries posted fourth-quarter profit above estimates on...